Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1983 | 12-1982 | 12-1981 | 12-1980 | 12-1979 | |
| Sales | 3,764,700 | 3,496,000 | 3,280,900 | 3,029,300 | 2,746,000 |
| Cost of Goods | 1,548,200 | 1,554,300 | 1,567,800 | 1,449,000 | 1,323,800 |
| Gross Profit | 2,216,500 | 1,921,300 | 1,698,700 | 1,580,300 | 1,422,200 |
| Operating Expenses | 1,456,700 | 1,330,200 | 1,197,300 | 1,095,200 | 976,000 |
| Operating Income | 760,000 | 611,800 | 516,600 | 485,100 | 447,000 |
| Interest Expense | 95,600 | 115,400 | 132,600 | 107,800 | 87,700 |
| Other Income | 38,200 | 53,900 | 58,300 | 32,700 | 6,300 |
| Pre-tax Income | 702,600 | 550,300 | 442,300 | 410,000 | 365,600 |
| Income Tax | 248,400 | 208,600 | 160,100 | 149,000 | 120,600 |
| Net Income Continuous | 448,400 | 336,300 | 276,500 | 253,900 | 237,900 |
| Net Income Discontinuous | 0 | 0 | -52,400 | 0 | 0 |
| Net Income | $448,400 | $336,300 | $224,100 | $253,900 | $237,900 |
| EPS Basic Total Ops | 0.12 | 0.09 | 0.06 | 0.07 | N/A |
| EPS Basic Continuous Ops | 0.12 | 0.09 | 0.08 | 0.07 | N/A |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.01 | N/A | N/A |
| EPS Diluted Total Ops | 0.12 | 0.04 | 0.03 | 0.07 | N/A |
| EPS Diluted Continuous Ops | 0.12 | 0.04 | 0.04 | 0.07 | N/A |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.01 | N/A | N/A |
| EBITDA(a) | $760,000 | $611,800 | $516,600 | $485,100 | $447,000 |